Serum C-reactive protein (CRP) levels in young adults can be used to discriminate between inflammatory and non-inflammatory diarrhea

Digestive Diseases and Sciences

Volumn 58, Issue 2, 2013, Pages 504-508

  Kim, Dong Hwan ^a   Kang, Sun Hyung ^a   Jeong, Woo Suk ^a   Moon, Hee Seok ^a   Lee, Eaum Seok ^a   Kim, Seok Hyun ^a   Sung, Jae Kyu ^a   Lee, Byung Seok ^a   Jeong, Hyun Yong ^a  

^a Chungnam National University College of Medicine   (South Korea)

Author keywords

C reactive protein (CRP); Inflammatory diarrhea; Non inflammatory diarrhea

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ACUTE DIARRHEA; ACUTE GASTROENTERITIS; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST RADIOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INFECTIOUS DIARRHEA; INFLAMMATORY DISEASE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLIC HOSPITAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BLOOD; GASTROENTERITIS; IMMUNOLOGY; METABOLISM; MULTIVARIATE ANALYSIS; RISK FACTOR; SOLDIER;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; FEMALE; GASTROENTERITIS; HUMANS; MALE; MILITARY PERSONNEL; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

MLCS; MLOWN;

EID: 84876341045     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2365-3     Document Type: Article

References (22)

1. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ. 1992;70:705-714.
2. Guerrant RL, Shields DS, Thorson SM, Schorling JB, Groschel DH. Evaluation and diagnosis of acute infectious diarrhoea. Am J Med. 1985;78:91-98.
3. Vernacchio L, Vezina RM, Mitchell AA, Lesko SM, Plaut AG, Acheson DW. Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology. Pediatr Infect Dis J. 2006;25:2-7.
4. Bardhan PK, Beltinger J, Beltinger RW, Hossain A, Mahalanabis D, Gyr K. Screening of patients with acute infectious diarrhoea: evaluation of clinical features, faecal microscopy, and faecal occult blood testing. Scand J Gastroenterol. 2000;35:54-60.
5. Stoll B, Glass R, Banu H, Huq MI, Khan MU, Ahmed M. Value of stool examination in patients with diarrhoea. Br Med J. 1983;286:2037-2040.
6. Ashraf H, Beltinger J, Alam NH, et al. Evaluation of faecal occult blood test and lactoferrin latex agglutination test in screening hospitalized patients for diagnosing inflammatory and non-inflammatory diarrhoea in Dhaka, Bangladesh. Digestion. 2007;76:256-261. Epub. 01/14/2008.
7. McCartney AC, Orange GV, Pringle SD, Wills G, Reece IJ. Serum C reactive protein in infective endocarditis. J Clin Pathol. 1988;41:44-48.
8. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial versus viral infections. Pediatr Infect Dis J. 1999;18:875-881.
9. Schumann RR, Zweigner J. A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med. 1999;37:271-274.
10. Elsing C, Ernst S, Kayali N, Stremmel W, Harenberg S. Lipopolysaccharide binding protein interleukin-6 and C-reaction protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy. Infection. 2011;39:327-331.
11. Lubasch A, Lode H. The role of antibiotic therapy in infectious enteritis. Internist. 2000;41:494-497.
12. Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;15:12-15.
13. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554.
14. World Health Organization (WHO). WHO Report on Infectious Disease: Removing Obstables to Healthy Development. Geneva: WHO; 1999.
15. World Health Organization (WHO). WHO Report on Infectious Disease: Overcoming Antimicrobial Resistance. Geneva: WHO; 2000.
16. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291:827-835.
17. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
18. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206-217.
19. DuPont HL. Guidelines on acute infectious diarrhea in adults. The practice parameters committee of the American College of Gastroenterology. Am J Gastroenterol. 1997;92:1962-1975.
20. Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis. 1996;22:1019-1025.
21. Goodman LJ, Trenholme GM, Kaplan RL, et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med. 1990;150:541-546.
22. Cadwgan AM, Watson WA, Laing RB, MacKenzie AR, Smith CC, Douglas JG. Presenting clinical features and C-reactive protein in the prediction of a positive stool culture in patients with diarrhoea. J Infect. 2000;41:159-161.